Friday, July 21, 2017 11:34:45 AM
I've doubled down on CYTR this week, and am going to hold until I see a pps more reflective of the stock's value. If the data on ALDOX isn't cooked and is indeed 100% factual, I don't see any way to lose $$ based on my avg pps at present. If the FDA is buying it, so will I. If it turns out in actual application to have been incorrect and/or they pull ALDOX for whatever reason, I hope I'm long gone! ;p
Anything else of a positive nature that comes out in between will just be icing on the cake.
All IMO. GLTA/CYTR!
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM